Atlas Trials

Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema

Clinical trial NCT05300542 · COMPLETED

Trial details

NCT number
NCT05300542
Sponsor
Amazentis SA
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
ErythemaSun Damaged SkinSkin Inflammation
Start date
2022-03-17
Primary completion
2022-03-31
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.